The effect of psychological intervention combined with standard pharmacological therapy in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): A randomized controlled trial
Abstract
Background: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) often coexists with anxiety and depression. This study assessed whether adding psychological intervention (PI) to standard pharmacotherapy improves patient outcomes.
Methods: One hundred sixty eight adult patients diagnosed with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) were recruited for this study. They were randomly divided into control and PI groups. All patients in both groups received a 30-day standard prostatitis pharmacotherapy regimen with levofloxacin and tamsulosin. Additionally, the 84 patients in the PI group received PIs, unlike those in the control group. The self-rating depression scale and self-rating anxiety scale were employed to assess the psychological symptoms before and 3 months after the therapeutic treatments.
Results: Following treatment, the PI group exhibited significantly better recovery from symptoms of anxiety, depression, and prostatitis compared to the control group. Multiple linear regression analysis revealed that patients with longer disease durations had higher self-rating anxiety scale, self-rating depression scale, and National Institutes of Health-Chronic Prostatitis Symptom Index Scale scores. The study demonstrated that PI has positive early effects on patients with CP/CPPS. However, its efficacy decreases as the duration of the disease progresses.
Conclusion: The combination of PI and conventional antibiotics is effective for CP/CPPS patients…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 84 participants or records.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.